This page uses content from Wikipedia and is licensed under CC BY-SA.

Oxitropium bromide

Oxitropium bromide
Oxitropium bromide.svg
Clinical data
Trade namesOxivent, Tersigan, Tersigat, Ventilat
SynonymsN-Ethylscopolammonium bromide; Ba 253; Ba 253BR-L; Ba 253Br; Hyoscine ethobromide; N-Ethylnorscopolamine methyl bromide; Scopolamine ethobromide
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.045.543 Edit this at Wikidata
Chemical and physical data
FormulaC19H26BrNO4
Molar mass412.32 g/mol g·mol−1
3D model (JSmol)

Oxitropium bromide (trade names Oxivent, Tersigan) is an anticholinergic used as a bronchodilator for the treatment of asthma and chronic obstructive pulmonary disease.[1]

It was patented in 1966 and approved for medical use in 1983.[2]

References

  1. ^ Restrepo, R. D. (2007). "Use of inhaled anticholinergic agents in obstructive airway disease". Respiratory care. 52 (7): 833–851. PMID 17594728.
  2. ^ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 447. ISBN 9783527607495.